All Biotech News

List of articles in category All Biotech News
Title	Published Date
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency	09/13/2022
SOTIO Strengthens Management Team with Appointment of Robyn Hunter as Chief Financial Officer	09/12/2022
MIMETAS Appoints Dhaval Patel as Chair of the Board of Directors	09/08/2022
ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine	09/07/2022
Cellbox Solutions Expands to Israeli Market Via Partnership with BioGate Ltd.	09/07/2022
EpiEndo Commences LPS Challenge Trial for Lead Candidate EP395	08/31/2022
ProtonDx’s Dragonfly Diagnostic System Successfully Deployed at the 2022 Commonwealth Games	08/31/2022
European Commission Approves FYB201/Ranivisio®(1) (Ranivisio - Ranibizumab), a Biosimilar to Lucentis®(2)	08/29/2022
ProBioGen Executes a Master Service Agreement with NextPoint Therapeutics and Starts an Integrated Project from Cell Line Development to GMP Manufacturing	08/17/2022
BD, Accelerate Diagnostics Announce Global Commercial Collaboration	08/15/2022
CYTENA Unveils New Generation of B.SIGHT, a Fully Automated Single-Cell Dispenser for Microorganisms	08/08/2022
U.S. Food and Drug Administration (FDA) Approves FYB201/CIMERLI™* (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis®**	08/03/2022
BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology	08/01/2022
SOTIO Doses First Patient in AURELIO-04 Phase 2 Trial of SOT101 in Combination with KEYTRUDA® (pembrolizumab)	07/26/2022
Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney	07/26/2022
Polpharma Biologics Announces FDA File Acceptance for Review of Natalizumab, First Proposed Biosimilar to Tysabri®	07/25/2022
NEOsphere Biotechnologies Closes Financing Round to Discover Therapeutic Protein Degraders Via Expanded Proteomics Platform	07/25/2022
Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing	07/20/2022
Apaxen Appoints Graham K. Dixon as Chairman and Prepares for Clinical Testing of its Lead Inflammasome Inhibitor	07/18/2022
Polpharma Biologics Announces EMA Acceptance of Marketing Authorization Application for Proposed Biosimilar Natalizumab	07/15/2022
ProBioGen Teams Up with Granite Bio for Cell Line Development and GMP Manufacturing Services	07/12/2022
Accelerate Diagnostics Announces Commercialization in Europe of its Accelerate Arc™ System Having Completed IVDR Registration	07/11/2022
ProteoNic Announces Licensing of its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio	07/05/2022
Vetter’s Newest Clinical Manufacturing Site Successfully Completed its First Customer Fills	06/28/2022
Richard Wales, Ph.D., and Neil Bargh of Sartorius Honored as Recipients of 2022 ESACT Innovation Award for the Development of the Sartorius Ambr® Technology	06/28/2022
ICPO Foundation Presents its first Maurits W. Geerlings Actinium-225 Next Generation Award to Dr. Madhav Yadav from AIIMS, India at the 6th Theranostics World Congress (TWC)	06/28/2022
Ixaka and Minaris Regenerative Medicine Sign Tech Transfer and GMP Manufacturing Agreement for Lead Cell Therapy Candidate REX-001	06/27/2022
ProtonDx New Rapid Multi-Viral Pathogen Detection System Receives CE-IVD Mark	06/21/2022
ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to GenScript ProBio	06/15/2022
ValenzaBio Engages ProBioGen For a Second Service Project	06/14/2022

Page 15 of 88